Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. (JEWEL II)

Viatris

Status and phase: Completed; Phase 4

Conditions: Hypertension; Hyperlipidemia

Treatments: Drug: Amlodipine/atorvastatin single pill

Study type: Interventional

Funder types: Industry

Identifiers

NCT00174304

A3841029

Details and patient eligibility

About

To evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Treated or untreated subjects with concurrent hypertension and dyslipidemia with BP and LDL-C not at target according to governing guidelines

Exclusion criteria

• High liver enzymes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)